4,820,000 Shares of Common Stock Barrier Therapeutics, Inc. (a Delaware corporation) Common Stock Underwriting AgreementUnderwriting Agreement • September 15th, 2006 • Barrier Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 15th, 2006 Company Industry JurisdictionBarrier Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Underwriters named in Schedule I annexed hereto (the “Underwriters”) an aggregate of 4,820,000 shares of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company (the “Firm Shares”). The Firm Shares are also referred to as the “Offered Securities.”